Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death

被引:165
|
作者
Dalrymple, Lorien S. [1 ]
Katz, Ronit [2 ]
Kestenbaum, Bryan [3 ]
Shlipak, Michael G. [4 ,5 ]
Sarnak, Mark J. [6 ]
Stehman-Breen, Catherine [7 ]
Seliger, Stephen [8 ]
Siscovick, David [9 ]
Newman, Anne B. [10 ,11 ]
Fried, Linda [10 ,11 ,12 ]
机构
[1] Univ Calif Davis, Dept Med, Sacramento, CA 95817 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Med, Seattle, WA 98195 USA
[4] Vet Affairs Med Ctr, Med Serv, Gen Internal Med Sect, San Francisco, CA 94121 USA
[5] Univ Calif San Francisco, Dept Med, San Francisco, CA USA
[6] Tufts Med Ctr, Dept Med, Boston, MA USA
[7] Amgen Inc, Thousand Oaks, CA 91320 USA
[8] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[9] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[10] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA USA
[11] Univ Pittsburgh, Sch Med, Dept Epidemiol, Pittsburgh, PA USA
[12] VA Pittsburgh Hlth Care Syst, Renal Sect, Pittsburgh, PA USA
关键词
renal disease; cardiovascular disease; clinical epidemiology; CARDIOVASCULAR EVENTS; OLDER-ADULTS; MORTALITY; OUTCOMES; POPULATION;
D O I
10.1007/s11606-010-1511-x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Among older adults with chronic kidney disease (CKD), the comparative event rates of end-stage renal disease (ESRD) and cause-specific death are unknown. To compare the rates of ESRD, cardiovascular and non-cardiovascular death and examine risk factors for ESRD and all-cause mortality in Cardiovascular Health Study (CHS) participants. The CHS is a longitudinal cohort study of community-dwelling adults aged 65 years and older. 1,268 participants with an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m(2) were followed until the time of first event (ESRD, cardiovascular or non-cardiovascular death) or until March 31, 2003. The outcomes were ESRD, cardiovascular- and non-cardiovascular death. Rates of each event were calculated, and a Cox Proportional Hazards Model with a competing risk framework was used to examine risk factors for ESRD as compared with death. Predictors included age, gender, race, BMI, hypertension, diabetes, cardiovascular disease, heart failure, tobacco use, eGFR, and total cholesterol. During 9.7 years of follow-up, 5% of the cohort progressed to ESRD, and 61% of the cohort died. The rate (per 100 person-years) was 0.5 for ESRD and 6.8 for all-cause mortality (3.0 for cardiovascular and 3.8 for non-cardiovascular mortality). In the competing risk framework, lower eGFR, male gender, African-American race, and higher BMI were associated with an increased risk of ESRD. Older adults with CKD are 13-fold more likely to die from any cause than progress to ESRD and are 6-fold more likely to die from cardiovascular causes than develop ESRD.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [1] Chronic Kidney Disease and the Risk of End-Stage Renal Disease versus Death
    Lorien S. Dalrymple
    Ronit Katz
    Bryan Kestenbaum
    Michael G. Shlipak
    Mark J. Sarnak
    Catherine Stehman-Breen
    Stephen Seliger
    David Siscovick
    Anne B. Newman
    Linda Fried
    [J]. Journal of General Internal Medicine, 2011, 26 : 379 - 385
  • [2] Blood Pressure Components and the Risk for End-Stage Renal Disease and Death in Chronic Kidney Disease
    Agarwal, Rajiv
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (04): : 830 - 837
  • [3] Risk of End-Stage Renal Disease and Death After Cardiovascular Events in Chronic Kidney Disease
    Sud, Maneesh
    Tangri, Navdeep
    Pintilie, Melania
    Levey, Andrew S.
    Naimark, David
    [J]. CIRCULATION, 2014, 130 (06) : 458 - +
  • [4] Homelessness and Risk of End-Stage Kidney Disease and Death in Veterans With Chronic Kidney Disease
    Koyama, Alain K.
    Nee, Robert
    Yu, Wei
    Choudhury, Devasmita
    Heng, Fei
    Cheung, Alfred K.
    Cho, Monique E.
    Norris, Keith C.
    Yan, Guofen
    [J]. JAMA NETWORK OPEN, 2024, 7 (09)
  • [5] Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease
    Jiang, Yue
    Fine, Jason P.
    Mottl, Amy K.
    [J]. ADVANCES IN CHRONIC KIDNEY DISEASE, 2018, 25 (02) : 133 - 140
  • [6] Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease
    Dieter, Brad P.
    McPherson, Sterling M.
    Afkarian, Maryam
    de Boer, Ian H.
    Mehrotra, Rajnish
    Short, Robert
    Barbosa-Leiker, Celestina
    Alicic, Radica Z.
    Meek, Rick L.
    Tuttle, Katherine R.
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (08) : 1467 - 1472
  • [7] END-STAGE RENAL DISEASE AND CHRONIC KIDNEY DISEASE IN BRAZIL
    Lugon, Jocemir R.
    [J]. ETHNICITY & DISEASE, 2009, 19 (01) : 7 - 9
  • [8] Relationship between chronic kidney disease prevalence and end-stage renal disease risk
    Hallan, Stein Ivar
    Vikse, Bjorn Egil
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (03): : 286 - 291
  • [9] Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease
    Lu, Chung-Yen
    Chen, Yin-Cheng
    Lu, Yu-Wen
    Muo, Chih-Hsin
    Chang, Ray-E
    [J]. BMC NEPHROLOGY, 2019, 20 (01)
  • [10] Association of Constipation with risk of end-stage renal disease in patients with chronic kidney disease
    Chung-Yen Lu
    Yin-Cheng Chen
    Yu-Wen Lu
    Chih-Hsin Muo
    Ray-E Chang
    [J]. BMC Nephrology, 20